Galectin Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	163	78	93	63	108	105
Market Cap Growth	107.53%	-15.81%	47.83%	-41.83%	3.34%	-27.91%
Enterprise Value	262	158	133	79	96	80
Last Close Price	2.40	1.08	1.45	1.06	1.89	1.82
PB Ratio	-1.54	-0.79	-1.70	-2.09	46.96	5.29
P/TBV Ratio	-	-	-	-	335.62	5.83
Debt / Equity Ratio	-1.02	-1.03	-1.19	-1.24	11.11	0.00
Net Debt / Equity Ratio	-0.93	-0.88	-0.77	-0.66	-4.05	-1.12
Quick Ratio	0.08	0.43	1.64	1.43	4.39	5.03
Current Ratio	0.09	0.49	1.77	1.58	4.63	5.46
Return on Equity (ROE)	-	-	-	-	-227.74%	-67.25%
Return on Assets (ROA)	-87.09%	-116.08%	-96.17%	-75.96%	-52.81%	-37.54%
Return on Capital Employed (ROCE)	23.60%	236.90%	-304.00%	-463.60%	-92.00%	-96.90%
Earnings Yield	-19.63%	-58.11%	-40.00%	-57.74%	-24.85%	-18.35%
Buyback Yield / Dilution	-2.12%	-3.57%	-1.29%	-1.48%	-2.63%	-9.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.